SEC Form 3 · accession 0000899243-18-013591
Whitehawk Therapeutics, Inc. · WHWK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dhaval Desai
Officer — Chief Strategy Officer
Period of report
May 9, 2018
Accepted (ET)
May 21, 2018 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422142
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 75,342 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.80 | holding | — | — | — | — | May 12, 2026 | Common Stock | 50,228 | — | D |
| Stock Option (Right to Buy)F2 | $3.59 | holding | — | — | — | — | Apr 23, 2028 | Common Stock | 100,000 | — | D |
Explanation of responses
- F1This option shall vest in 48 equal monthly installments from the vesting commencement date.
- F225% shares shall vest on the one year anniversary of the vesting commencement date, then the remaining shares shall vest in equal monthly installments for the remaining 36 months.
Remarks
Exhibit 24.1: Power of Attorney